Immune milieu and genomic alterations set the triple-negative breast cancer immunomodulatory subtype tumor behavior

HIGHLIGHTS

• who: Rubu00e9n Rodru00edguez-Bautista and collaborators from the Laboratorio Medicina Personalizada la Unidad Oncologu00eda Toru00e1cica, Instituto Nacional, Facultad Medicina, Universidad Nacional Autu00f3noma Mu00e9xico (UNAM), Mexico City, Mexico have published the research: Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior, in the Journal: (JOURNAL)
• what: The analysis showed a higher but non-significant intT infiltration of CD8+ (Th1) TILs in the IM subtype when compared with the non-IM subtype (20% (95% CI: 9.4-38.6) vs. 10% (7.16-15.45); p=0.058) . The results from . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.